Kidney Cancer

As pioneers in the diagnosis and treatment of kidney cancer, our team of experts treats people who travel from all over the world to seek our care. We use sophisticated imaging tests, including specialized MRI and CT scans, and our surgeons are leaders in robotic-assisted and organ-sparing surgical techniques. What’s more, we are one of the only medical centers in New York to offer interleukin 2, a medication that is the only treatment known to lead to remission in kidney cancer that has spread.

Clinical Trials and Research Studies

Phase 1

Phase 1b Open-label Study of MK-7162 in Combination with Pembrolizumab (MK-3475) +/- other therapies in Participants with Advanced Solid Tumors

Phase 1

A Phase 1 Open-Label Dose-Escalation and Cohort Expansion First-in-Human Study of the Safety Tolerability Activity and Pharmacokinetics of REGN3767 (anti-LAG-3 mAb) Administered Alone or in Combination with REGN2810 (anti-PD-1 mAb) in Patients with Ad

Phase 1/2

A Phase I/IIa Study of BMS-986205 Administered in Combination with Nivolumab (BMS-935558 anti-PD-1 Monoclonal Antibody) in Advanced Malignant Tumors

Phase 3

Phase 3b/4 Safety Trial of Nivolumab Combined with Ipilimumab in Subjects with Previously Untreated Advanced or Metastatic RCC